Le Lézard
Classified in: Health
Subject: MAT

Shady Grove Fertility Tampa Bay announces expansion with a fourth location coming soon to St. Petersburg, Florida


US Fertility partner practice, Shady Grove Fertility Tampa Bay, is proud to expand access to high-quality fertility care to individuals and couples in St. Petersburg, Florida.

ST. PETERSBURG, Fla., Aug. 25, 2022 /PRNewswire-PRWeb/ -- Shady Grove Fertility Tampa Bay, a founding partner practice of US Fertility, announces a new St. Petersburg location is coming soon. Rachel Sprague, M.D., is now accepting virtual appointments, with in-person appointments available later this fall. Now, with four locations, SGF Tampa Bay provides greater access to comprehensive fertility care in the Tampa Bay area.

"I am privileged to be surrounded by a compassionate and committed fertility care team who constantly strive to make a positive difference in the lives of their patients," shares Dr. Sprague. "Coming to St. Petersburg, we will expand on Shady Grove Fertility's reputation of practicing high-quality, evidence-based medicine for the betterment of our patients."

Located in Suite 475 of the Bayfront Medical Plaza at 603 Seventh Street South, SGF Tampa Bay's St. Petersburg location provides the community more convenient access to highly specialized fertility care, including:

About Dr. Sprague

Dr. Sprague earned her medical degree from the University of Florida College of Medicine. She pursued her residency in obstetrics and gynecology at the University of Alabama at Birmingham, where she served as Residency Class Lieutenant and earned the Fund for Excellence in Research Award. Dr. Sprague then traveled to Florida to complete her fellowship in reproductive endocrinology and infertility at Morsani College of Medicine at the University of South Florida.

Exemplifying Dr. Sprague's passion for research are her contributions to research abstracts presented at medical conferences nationwide on topics including the environmental effects on a person's ovarian reserve, preimplantation genetic testing, and endometriosis. Additionally, Dr. Sprague contributed a book chapter on in vitro fertilization in the Encyclopedia of Reproduction, Second Edition. Dr. Sprague is a member of several professional organizations, including the American Congress of Obstetrics and Gynecology, the American Medical Association, the American Society for Reproductive Medicine, and the Pacific Coast Reproductive Society.

"When I met Dr. Sprague, she took time to listen to me," shared SGF Tampa Bay patient Kandice. "She gave me options and educated me on my next steps. I'm excited to start the path to fertility armed with knowledge and understanding."

Patients may now schedule a virtual new patient appointment with Dr. Sprague by calling SGF's New Patient Center at 1-888-761-1967 or by submitting this brief form.

About US Fertility
US Fertility?is the nation's largest partnership of physician-owned and physician-led top-tier fertility practices, offering comprehensive fertility-market-focused non-clinical, administrative, and technical platforms that help domestic and international practices improve patient outcomes and increase patient access. To learn more about partnership- or affiliate-status benefits, call 301-545-1308 or visit?USFertility.com.

About Shady Grove Fertility (SGF)
SGF is a leading fertility and IVF center of excellence with more than 100,000 babies born from 30+ years of continuous innovation and patient-centered fertility care. With 48 locations, including new locations in Texas, as well as throughout CO, FL, GA, MD, NY, PA, TX, VA, D.C., and Santiago, Chile, SGF offers patients in-person and virtual physician consults, delivers individualized care, accepts most insurance plans, and makes treatment affordable through innovative financial options, including 100% refund guarantees. SGF is among the founding partner practices of US Fertility, the largest physician-led partnership of top-tier fertility practices in the U.S. Call 1-888-761-1967 to schedule a new patient appointment or visit ShadyGroveFertility.com for more information.

Media Contact

Jean Dzierzak, Shady Grove Fertility, 301-545-1375, [email protected]

 

SOURCE Shady Grove Fertility


These press releases may also interest you

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...



News published on and distributed by: